Benzinga | Nov 23, 2021 07:47AM EST

Wolfe Research Upgrades Calumet Specialty to Outperform, Announces $30 Price Target

Wolfe Research analyst Sam Margolin upgrades Calumet Specialty (NASDAQ:CLMT) from Peer Perform to Outperform and announces $30 price target.